Home > Boards > Free Zone > All Trading - Technical > General Stock Ideas

There's a high degree of confidence in the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ombowstring Member Profile
 
Followed By 19
Posts 4,313
Boards Moderated 0
Alias Born 09/27/05
160x600 placeholder
Four-Woman Group That Fought U.K. Algorithms Steps Up for Tech-Worker Rights
LONDON -- A four-woman technology-advocacy group that forced the British government to scrap a controversial algorithm for processing visas and led a public backlash over a tool for predicting high-school grades now is taking on Facebook Inc. and Uber Technologies Inc. over worker rights.
CEOs Can't Avoid Politics, Says Pernod Ricard Executive: 'We Are All in the Fray'
Zack Snyder's 'Army of the Dead' and Other Netflix Movies Turn Up in Theaters
Former Apple Engineer Accuses Company of Defamatory Statements Over Dismissal
Vivendi: Procedures for Obtaining or Consulting Information on the Combined General Shareholders' Meeting to be Held on June ...
Walmart to Stop Requiring Masks for Vaccinated Workers and Shoppers -- 2nd Update
Top Company News of the Day
PNC Receives Regulatory Approval to Acquire BBVA USA
McDonald's, Tesla, Disney: Stocks That Defined the Week
Hertz Gets Court Approval for Bankruptcy Deal With Top Bidders -- Update
Correction to Amazon 75,000 Workers Article on May 13
Walmart to Stop Requiring Masks for Vaccinated Workers and Shoppers -- Update
Top Stories of the Day
Walmart to Stop Requiring Masks for Vaccinated Workers and Shoppers
IPO Market Faces a Critical Juncture
Stocks Rebound but Suffer Weekly Losses
Hertz Gets Court Approval for Bankruptcy Deal With Top Bidders Knighthead and Certares
Why the CDC Told Fully Vaccinated Americans They Didn't Need to Wear Face Masks Anymore
Matt Gaetz Associate Joel Greenberg Set to Plead Guilty to Sex Trafficking
Bank of America Reaches Tentative $75 Million Settlement in Excessive Fees Case, Reuters Reports
Stock Gains Accelerate in Afternoon Trading
ombowstring   Wednesday, 07/15/20 12:11:08 PM
Re: gfp927z post# 17574
Post # of 19212 
There's a high degree of confidence in the results of the Phase 2 trial based on the experiences of the people treated under the EIND process. If you HAD to bet on it one way or the other, where would you put your money?

https://en.wikipedia.org/wiki/Data_monitoring_committee

>>> Overwhelming benefit

In the fortunate situation that the experimental arm is shown to be undeniably superior to the control arm the DMC may recommend termination of the trial. This would allow the company sponsoring the trial to get regulatory approval earlier and to allow the superior treatment to get to the patient population earlier. There are cautions here though. The statistical evidence needs to be very high indeed.[citation needed] Also, there might be other reasons to continue, such as collecting more long-term safety data. <<<

If the committee lives up to its responsibilty, leronlimab should be a cinch to get FDA approval.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences